List of Drugs for an Urgent Public Health Need

The List of Drugs for an Urgent Public Health Need (the List) contains the following drug-related details: the brand name, the medicinal ingredient(s), the route of administration, the strength, the dosage form and the identifying code or number, if any, assigned in the country in which the drug was authorized for sale.

The List also contains other information obtained through the public health official notification, including: the foreign regulatory authority which authorized the drug, the foreign country from which the drug can be imported, the Canadian jurisdiction notifying for the drug (i.e., the Canadian jurisdiction in which the drug is allowed to be sold), the urgent public health need for the drug, the intended use or purpose of the drug (i.e., the purpose for which the drug must be used in the Canadian jurisdiction) and the date of notification by a public health official.

A public health official notification allows a listed drug to be imported into Canada and sold in the notifying jurisdiction for a period of 1 year. If a notification has not been renewed by a public health official within one year of the initial notification, the drug will no longer be eligible for importation and sale. Drugs may also be removed from the List at any time at the Minister's discretion.

A drug is only eligible for importation and sale if all columns on the List are populated, including columns located under the "For Information Purposes" subheading.

(PDF Version - 102 KB, 2 pages)

List of Drugs for an Urgent Public Health Need
Brand name Medicinal Ingredient(s) Dosage form
Strength
Route of administration
Foreign identifying code or number For Information Purposes
Foreign regulatory authority/ Foreign country Canadian jurisdiction notifying for the drug/Date of notification by a public health official Urgent public health need - Applicable Foreign Authorised Indication (Intended use or purpose of the drug)
Priftin
Rifapentine
Tablet
150mg
Oral
0088-2100-24 FDA/USAFootnote 1
Important foreign identified risk information-see footnote below
First Nations and Inuit Health Branch/January 26, 2021 Tuberculosis crisis –
For the treatment of latent turberculosis infection (LTBI) caused by Mycobacterium tuberculosis in combination with isoniazid in patients at high risk of progression to TB disease.
Suboxone
Buprenorphine hydrochloride; Naloxone hydrochloride
Film
2 mg/0.5 mg;
8 mg/2 mg;
12 mg/3 mg
Buccal, Sublingual
12496-1202-3
12496-1208-3
12496-1212-3
FDA/USA Public Health Agency of Canada - for use in Correctional Service Canada Facilities/ August 14, 2020 Opioid crisis –
For the treatment of opioid dependence and as part of a complete treatment plan to include counseling and psychosocial support.
Diaphin i.v.
Diamorphine
Injectable
10 g/vial
Intravenous
55561 Swissmedic/Switzerland Public Health Agency of Canada - for use in all jurisdictions/ April 9, 2021 Opioid crisis –
Substitution therapy in case of severe heroin dependence as part of a treatment program with prescription heroin.
Priftin
Rifapentine
Tablet
150 mg
Oral
0088-2102-24 FDA/USAFootnote 1
Important foreign identified risk information-see footnote below
Public Health Agency of Canada - for use in all jurisdictions/ April 13, 2021 Tuberculosis crisis –
For the treatment of latent turberculosis infection (LTBI) caused by Mycobacterium tuberculosis in combination with isoniazid in patients at high risk of progression to TB disease.
Influsplit Tetra (single dose prefilled syringe)
Quadrivalent, split-virion, inactivated influenza A and B virus strains
Suspension for Injection
0.5 mL (single dose prefilled syringe) Intramuscular
11629.01.1 Paul-Ehrlich-Institute/ Germany Public Health Agency of Canada - for use in all jurisdictions/ November 18, 2020 Influenza Immunization –
Indicated for active immunization for the prevention of influenza disease caused by the two influenza A virus subtypes and the two influenza B viruses contained in the vaccine.
FluMist Quadrivalent (prefilled intranasal spray)
Quadrivalent live attenuated influenza A and B virus strains
Spray
0.2 mL (prefilled intranasal sprayer) Intranasal
66019-307-10 FDA/USA Public Health Agency of Canada - for use in all jurisdictions/ November 18, 2020 Influenza Immunization –
Indicated for active immunization for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.
Diaphin IR 200
Diamorphine
Tablet
200 mg
Oral
57724 Swissmedic/ Switzerland British Columbia/April 14, 2021 Opioid crisis –
Substitution therapy in case of severe heroin dependence as part of a treatment program with prescription heroin.
Diaphin SR 200
Diamorphine
Tablet
200 mg
Oral
57720 Swissmedic/ Switzerland British Columbia/April 14, 2021 Opioid crisis –
Substitution therapy in case of severe heroin dependence as part of a treatment program with prescription heroin.

Footnotes

Footnote 1

Foreign Identified Risk:  Rifapentine has been identified by the US FDA as one of the drugs that contains nitrosamine impurities. For more information, please visit the US FDA website:
https://www.fda.gov/drugs/drug-safety-and-availability/fda-works-mitigate-shortages-rifampin-and-rifapentine-after-manufacturers-find-nitrosamine

Return to footnote 1 referrer

Related Information:

Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: